Wednesday, September 28, 2005

Dont hold your breath

SkyePharma believes AstraZeneca is unlikely to launch Symbicort, its combo asthma inhaler, in the US before 2008.

Source: Forbes

1 comment:

Anonymous said...

I found the quote:

http://www.forbes.com/markets/feeds/afx/2005/09/28/afx2248107.html